| Good morning Wake-Up Watchlisters! While you're sipping coffee for the daily rise and grind you'll see stock futures rose Monday. Investors are waiting for inflation data this week. Back in August, the consumer price index rose 8.1% over the prior year, a moderation from an 8.5% increase in July. There's no doubt inflation has hit wallets hard in 2022, which is why you need to protect your assets. Precious Metal IRAs could be a way to help keep your retirement in tact. And if your account qualifies, you can receive up to $10,000 or more in FREE silver. Click here to learn more about Precious Metal IRAs. Here's a look at the top-moving stocks this morning. Spectrum Pharmaceuticals (Nasdaq: SPPI) Spectrum Pharmaceuticals is up 20.46% premarket after the company received FDA approval for its Rolvedon™ drug. The approval marks Spectrum's transformation to a commercial-stage company with the opportunity to compete in a $2 billion market. The medical sector often provides some amazing investment opportunities. And our friend Alexander Green wants you to know about this new breakthrough technology. Its company is trading at just $3 and has only been public since 2020. Click here to discover this company. Bristol-Myers Squibb Company (NYSE: BMY) Bristol-Myers Squibb Company is up 6.90% premarket after the FDA approved its new plaque psoriasis treatment. The drug goes by the name 'Sotyktu' and is the first new treatment for adults suffering from moderate-to-severe plaque psoriasis in more than ten years. Bristol Myers says the drug could launch as early as next month. | 
Post a Comment
Post a Comment